Position Title: Copywriter Supervisor
Duration: 12 Months (Possible Extension)
Location: Remote (US time zones, PST alignment required) or Irvine, CA (Hybrid: 3 Days Onsite)
Work Model & Location Guidelines
- Hybrid Candidates: Local candidates work a 3-day hybrid schedule (Tuesday, Wednesday, Thursday) at the Irvine, CA office. Only local hybrid talent is eligible for future direct-hire conversion consideration should organizational needs allow.
- Remote Candidates: Fully remote candidates across the US are welcome for contract duration, provided they maintain daily operational alignment with Pacific Time (PST) and have flexibility for afternoon team meetings. Remote contracts will remain as contract engagements.
Required Qualifications
- Experience: 7-10+ years of pharmaceutical advertising agency copywriting experience.
- Audience Expertise: Proven track record writing for Healthcare Professionals (HCPs) and sales forces; prior exposure to patient/consumer touchpoints is a plus.
- Regulatory Acumen: Deep mastery of MLR/PRC submission requirements, referencing/annotating protocols, and ISI integration.
- Scientific Literacy: Demonstrated ability to independently read clinical trial data, interpret study design, and translate high-science mechanism of action (MOA) into compelling creative copy.
- Aesthetics / Beauty Affinity: Understanding of the tone required for aesthetic medicine-balancing clinical precision with a dynamic, lifestyle-driven editorial voice.
- Agility: Ability to pick up projects in flight, adapt to pivoting clinical/marketing inputs, and execute independently with minimal onboarding oversight.
- Education: Bachelor's degree required; degree in Arts, Communications, Science, or related field preferred.
Role Overview
We are seeking a highly skilled, hands-on Copywriter Supervisor / Associate Creative Director (Copy) to support high-profile commercial and launch-stage facial aesthetics brands. This role drives multi-channel creative and technical copy development across HCP and patient audiences, blending rigorous scientific accuracy with a charismatic, conversational, and premium aesthetic voice.
This position operates in a fast-paced environment supporting flagship portfolios and a major upcoming brand launch. The ideal candidate is a proactive problem-solver who thrives in high-volume, dynamic workflows, navigates the MLR/PRC review lifecycle seamlessly, and operates with a 70-80% hands-on execution focus.
Core Responsibilities
Creative Execution & Multi-Channel Copywriting (70-80%):
- Conceptualize and write high-impact copy across print, digital, social media, video/sizzle reels, national sales meeting assets, direct sales-enablement tools (Salesforce/BDM), and clinical injection guides.
- Translate complex clinical data and high science into accessible, inspirational, and modern language tailored specifically to healthcare providers (HCPs) in the aesthetics space.
- Perform end-to-end referencing and annotating for claims, ensuring strict adherence to ISI, black-box guidelines, and regulatory frameworks.
- Manage fast-evolving regulatory feedback (PRC/MLR), actively proposing creative solutions to claims, guidelines, and last-minute copy adjustments.
Workflow Ownership & Collaboration (15-20%):
- Partner daily with Art Directors, Editorial, Traffic, and Account partners to deliver integrated creative concepts on schedule.
- Prioritize deliverables autonomously amid competing deadlines, erratic launch cycles, and fluctuating brand volumes.
- Co-lead presentations of creative concepts internally and externally, articulating strategic rationale and scientific justification.
- Utilize pharma-standard workflows and asset management systems, including Veeva PromoMats.
Mentorship & Day-to-Day Copy Leadership (5-10%):
- Serve as a senior sounding board for peer writers-reviewing drafts, troubleshooting PRC comments, and guiding tactical execution (no formal HR performance reviews).
- Foster a collaborative, solution-oriented environment during high-intensity launches phases.
|
Spectraforce Technologies
Sep 15, 2026